In a TNBS rat colitis model, Escherichia coli Nissle 1917, at low doses of the strain (107cfu/day), has been demonstrated to reduce the disease activity index, colonic MPO activity, and TNF‐α levels and to increase IL‐10 expression (Sha et al., 2014). This evidence concerns the gene MPO and colitis.